AUG 17, 2016 06:43 AM PDT

Magnetic Bacteria Ferry Chemo Drugs to Resistant Tumors

WRITTEN BY: Xuan Pham
By combining nanotechnology and the wonderful world of microbiology, Canadian scientists have created something truly unique in the field of cancer medicine. Specifically, they leveraged the power of magnetotactic bacteria to create nanorobots that deliver chemotherapy agents directly into the tumor, even into the hardest to treat areas.
 
Legions of nanorobots target cancerous tumors with precision | Image: The NanoRobotics Laboratory, Polytechnique Montréal
"These legions of nanorobotic agents were actually composed of more than 100 million flagellated bacteria - and therefore self-propelled - and loaded with drugs that moved by taking the most direct path between the drug's injection point and the area of the body to cure," said Sylvain Martel, Director of the Polytechnique Montréal Nanorobotics Laboratory, and senior study author.
 
The technology sounds like science fiction come-to-life. The microbes behind this so-called legions of nanorobots are magnetotactic bacteria (Magnetococcus marinus strain MC-1). Discovered by Richard P. Blakemore in 1975, magnetotactic bacteria are tiny microorganisms that have the capacity to convert iron into magenetite inside organelles called magnetosomes. Each of the magnetite crystal acts as a nano-magnet, and a chain of these act as a built-in compass for north and south detection. The bacteria use these internal compasses to move and align themselves in watery regions with optimal oxygen concentrations.
 

Martel and his team exploited the unique characteristics of the magnetotactic bacteria to ferry drug-loaded lipososomes into tumors. In particular, M. marinus has a penchant for regions of low oxygen concentration. This makes them ideal carriers of chemotherapy drugs to tumors, since many contain hypoxic regions that are often resistant to therapies.
 
In mice experiments, Martel and his team showed the nanorobots could deliver drugs in a targeted fashion to colorectal tumors. "The drug's propelling force was enough to travel efficiently and enter deep inside the tumors,” he added.
 
The concept of using the bacteria-propelled nanorobots to control and target drug release could potentially minimize the chemotherapy-related collateral damages to the healthy cells. Furthermore, because of higher precision to the tumor, doctors may be able to use a lower dose of the drug to achieve the same potency. This would also curtail side-effects of chemotherapy.
 
“This innovative use of nanotransporters will have an impact not only on creating more advanced engineering concepts and original intervention methods, but it also throws the door wide open to the synthesis of new vehicles for therapeutic, imaging and diagnostic agents," said Martel. "Chemotherapy, which is so toxic for the entire human body, could make use of these natural nanorobots to move drugs directly to the targeted area, eliminating the harmful side effects while also boosting its therapeutic effectiveness."

Additional sources: Polytechnique Montréal press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 05, 2018
Cancer
JUN 05, 2018
Precision vs. Personalized Medicine Part I: Precision Approach
So often the phrases "Precision Medicine" and "Personalized Medicine" are used interchangeably. Are they really synonyms? Part I looks at Precision Medicine...
JUN 05, 2018
Cancer
JUN 05, 2018
Precision vs. Personalized Medicine Part II: Personalized Approach
So often the phrases "Precision Medicine" and "Personalized Medicine" are used interchangeably. Are they really synonyms? Part II looks at Personalized Medicine...
JUL 17, 2018
Cancer
JUL 17, 2018
Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR
CRISPR can be used to dupe circulating tumor cells into killing their own main tumor after "re-homing" back with a death receptor for tumor destruction....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
SEP 20, 2018
Genetics & Genomics
SEP 20, 2018
Liquid Phase Separation may Play a Role in Cancer
Not all liquids mix, like oil and water; the phenomenon is called liquid-liquid phase separation. We're learning more about its role in cells....
SEP 26, 2018
Cancer
SEP 26, 2018
Rare Cancer the Focus of Mesothelioma Awareness Day
More than 2,500 Americans are diagnosed with mesothelioma cancer each year. The cancer is rare but very serious - most patients diagnosed with the disease live just a short 12 to 21 months....
Loading Comments...